BR112012014490A2 - processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses - Google Patents

processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses

Info

Publication number
BR112012014490A2
BR112012014490A2 BR112012014490A BR112012014490A BR112012014490A2 BR 112012014490 A2 BR112012014490 A2 BR 112012014490A2 BR 112012014490 A BR112012014490 A BR 112012014490A BR 112012014490 A BR112012014490 A BR 112012014490A BR 112012014490 A2 BR112012014490 A2 BR 112012014490A2
Authority
BR
Brazil
Prior art keywords
arabinofuranoses
deoxy
thio
fluoro
acyl
Prior art date
Application number
BR112012014490A
Other languages
English (en)
Other versions
BR112012014490B1 (pt
Inventor
David Voigtlander
Michael Harre
Michael Sander
Original Assignee
Libramedicina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10163406A external-priority patent/EP2388257A1/en
Application filed by Libramedicina Inc filed Critical Libramedicina Inc
Publication of BR112012014490A2 publication Critical patent/BR112012014490A2/pt
Publication of BR112012014490B1 publication Critical patent/BR112012014490B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
BR112012014490-1A 2009-12-18 2010-12-03 Processos para a preparação de 1-o-acil-2-desóxi-2-fluoro-4-tio-?-d-arabinofuranoses e compostos intermediários dos mesmos BR112012014490B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09075563 2009-12-18
EP09075563.8 2009-12-18
EP10163406.1 2010-05-20
EP10163406A EP2388257A1 (en) 2010-05-20 2010-05-20 Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranoses
PCT/JP2010/072182 WO2011074484A1 (en) 2009-12-18 2010-12-03 PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSES

Publications (2)

Publication Number Publication Date
BR112012014490A2 true BR112012014490A2 (pt) 2015-09-15
BR112012014490B1 BR112012014490B1 (pt) 2021-07-13

Family

ID=43587023

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014490-1A BR112012014490B1 (pt) 2009-12-18 2010-12-03 Processos para a preparação de 1-o-acil-2-desóxi-2-fluoro-4-tio-?-d-arabinofuranoses e compostos intermediários dos mesmos

Country Status (16)

Country Link
US (2) US8329925B2 (pt)
EP (2) EP2513081B1 (pt)
JP (1) JP5616968B2 (pt)
KR (1) KR101814549B1 (pt)
CN (1) CN102656154B (pt)
AU (1) AU2010331367B2 (pt)
BR (1) BR112012014490B1 (pt)
CA (1) CA2784399C (pt)
IL (1) IL220357A (pt)
MX (1) MX2012006872A (pt)
MY (1) MY156954A (pt)
NZ (1) NZ601222A (pt)
RU (1) RU2559364C2 (pt)
SG (1) SG181745A1 (pt)
TW (1) TWI476204B (pt)
WO (1) WO2011074484A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170082650A (ko) 2012-03-28 2017-07-14 후지필름 가부시키가이샤 1-(2-디옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 염
CN103450148B (zh) * 2012-06-04 2018-06-12 浙江九洲药业股份有限公司 一种五元环硫酸酯化合物的合成方法
PT2883866T (pt) * 2012-08-13 2019-04-05 Fujifilm Corp Intermediário para a síntese de 1-(2-desoxi-2-fluoro-4-tiobeta-d-arabinofuranosilo)citosina, intermediário para a síntese de tionucleósido e métodos para a produção destes intermediários
CN103012386B (zh) * 2012-12-26 2015-04-01 浙江普洛得邦制药有限公司 一种五元环状硫酸酯的制备方法
JP6351107B2 (ja) * 2014-02-18 2018-07-04 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
JP6175553B2 (ja) * 2014-02-18 2017-08-09 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
JP6204223B2 (ja) 2014-02-19 2017-09-27 富士フイルム株式会社 チオピラノース化合物等の製造方法
JP6245527B2 (ja) * 2014-03-24 2017-12-13 富士フイルム株式会社 チオラン環もしくはチアン環骨格を有する化合物の製造方法
TWI678373B (zh) 2014-10-31 2019-12-01 日商富士軟片股份有限公司 硫代核苷衍生物或其鹽及醫藥組合物
JP6450356B2 (ja) 2016-02-29 2019-01-09 富士フイルム株式会社 液状医薬製剤
CN109641009B (zh) 2016-08-31 2021-12-31 富士胶片株式会社 抗肿瘤剂、抗肿瘤效果增强剂及抗肿瘤用试剂盒
CN106810541A (zh) * 2016-12-30 2017-06-09 苏州诚和医药化学有限公司 一种一步法制备索非布韦中间体的方法
JP2017214422A (ja) * 2017-09-01 2017-12-07 富士フイルム株式会社 サラシノールの製造に有用な化合物およびそれらの製造法、サラシノールの製造法、ジオール基の保護方法および脱保護方法、並びにジオール基の保護剤
AU2018404329B2 (en) 2018-01-29 2021-09-09 Fujifilm Corporation Antitumor agent for biliary tract cancer and method for treating biliary tract cancer
EP3766502A4 (en) 2018-03-13 2021-05-05 FUJIFILM Corporation ANTITUMOR DRUG, ANTITUMOR ENHANCER AND ANTITUMOR KIT
WO2023008511A1 (ja) 2021-07-29 2023-02-02 富士フイルム株式会社 Bap1およびpbrm1の少なくとも1つの機能低下を有する腫瘍に対する医薬組成物および抗腫瘍剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808272A (en) * 1986-06-20 1989-02-28 Spalding & Evenflo Companies, Inc. Method of constructing a mold for making game balls
US4803272A (en) * 1987-02-24 1989-02-07 E. I. Du Pont De Nemours And Company S-modified adenosyl-1,8-diamino-3-thiooctane derivatives
US5602268A (en) 1995-07-20 1997-02-11 Mallinckrodt Medical, Inc. Process for producing tungsten clusters
ATE224909T1 (de) 1996-04-09 2002-10-15 Yamasa Corp 1-(2-deoxy-2-fluoro-4-thio-beta-d- arabinofuranosyl)-cytosine
WO1997037993A1 (fr) 1996-04-09 1997-10-16 Yamasa Corporation DERIVES DE 9-(2-DESOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)PURINE
KR100426030B1 (ko) 2000-07-22 2004-04-03 (주) 한켐 락톤계 당화합물에서의 키랄성 전환방법
US20090069263A1 (en) 2005-12-16 2009-03-12 Damha Masad J 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof

Also Published As

Publication number Publication date
IL220357A0 (en) 2012-08-30
RU2012130422A (ru) 2014-01-27
US8329925B2 (en) 2012-12-11
AU2010331367A2 (en) 2013-01-24
JP2013514260A (ja) 2013-04-25
MX2012006872A (es) 2012-09-12
WO2011074484A1 (en) 2011-06-23
AU2010331367A1 (en) 2012-08-02
CN102656154A (zh) 2012-09-05
EP2799432A1 (en) 2014-11-05
IL220357A (en) 2015-11-30
EP2513081B1 (en) 2015-07-08
RU2559364C2 (ru) 2015-08-10
KR20120096088A (ko) 2012-08-29
BR112012014490B1 (pt) 2021-07-13
US8420831B2 (en) 2013-04-16
CA2784399A1 (en) 2011-06-23
US20130005991A1 (en) 2013-01-03
JP5616968B2 (ja) 2014-10-29
SG181745A1 (en) 2012-07-30
US20110152542A1 (en) 2011-06-23
EP2513081A1 (en) 2012-10-24
TW201121987A (en) 2011-07-01
MY156954A (en) 2016-04-15
CA2784399C (en) 2018-01-02
AU2010331367B2 (en) 2017-04-20
KR101814549B1 (ko) 2018-01-04
NZ601222A (en) 2013-09-27
EP2799432B1 (en) 2016-09-21
CN102656154B (zh) 2014-04-09
TWI476204B (zh) 2015-03-11

Similar Documents

Publication Publication Date Title
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI1013561A2 (pt) Processo para a preparação de alogliptina
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI1011672A2 (pt) processo para a preparação de fenol de ciclohexanona
BR112012003615A2 (pt) processo para a produção de butadieno
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BRPI1012370A2 (pt) processo para a produção de olefinas
BR112014012414A8 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112013010075A2 (pt) compostos intermediários e processo para a preparação de fingolimod
BRPI1014267A2 (pt) processo para a carbonitrificação
BRPI1013830A2 (pt) Processo para a iodação de compostos aromáticos
BR112012005418A2 (pt) processo para a produção de grânulos
BRPI0909393A2 (pt) processo para a preparação de polibutadieno
BR112012001274A2 (pt) processo para produção de ácidos decancarboxílicos
BR112012009789A2 (pt) processo para a produção de um álcool
BRPI1008117A2 (pt) Processo para a sintese de cleistantina
BRPI0813788A2 (pt) Processo para preparação de metacrilato de alila
BR112012001731A2 (pt) Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol
BRPI0911992A2 (pt) processo para preparação de bifenilanilidas substituídas
BRPI1010571A2 (pt) processo para a preparação de um composto útil como um inibidor de tafla.
BRPI0914792A2 (pt) processo para a preparação de polióis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 317/18 , C07D 333/32 , C07D 333/78

Ipc: C07D 317/18 (2006.01), C07D 333/32 (2006.01), C07D

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/12/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.